Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/17/24 17:22 | 1/12/24 | CELU | Health | Drug | Pharmaceutical Preparations | Lim Kok Thay | N8 | T | P.d | 5,331 | 0.2490 | 0 | 21,411 | 71 | 51,510 | I | |||||||||||||||
10/10/23 21:48 | 9/29/23 | CELU | Health | Drug | Pharmaceutical Preparations | Hariri Robert J | NJ | DO | CEO | P.m | 2,984 | 0.1620 | 0 | 18,422 | 182 | 28,570 | D | ||||||||||||||
11/30/22 19:55 | 11/30/22 | CELU | Health | Drug | Pharmaceutical Preparations | Hariri Robert J | NJ | DO | CEO | P | 17 | 1.72 | 0 | 10 | 0 | 8,075 | D | ||||||||||||||
11/29/22 19:53 | 11/29/22 | CELU | Health | Drug | Pharmaceutical Preparations | Hariri Robert J | NJ | DO | CEO | P | 68 | 1.71 | 0 | 40 | 0 | 8,065 | D | ||||||||||||||
11/28/22 19:13 | 11/28/22 | CELU | Health | Drug | Pharmaceutical Preparations | Hariri Robert J | NJ | DO | CEO | P | 70 | 1.74 | 0 | 40 | 1 | 8,025 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |